Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Front Immunol. 2021 Sep 3;12:720354. doi: 10.3389/fimmu.2021.720354. eCollection 2021.
Gut acute graft-versus-host disease (aGVHD) is a serious complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and is associated with high mortality. Mucosa-associated invariant T (MAIT) cells are a group of innate-like T cells enriched in the intestine that can be activated by riboflavin metabolites from various microorganisms. However, little is known about the function or mechanism of action of MAIT cells in the occurrence of gut aGVHD in humans. In our study, multiparameter flow cytometry (FCM) was used to evaluate the number of MAIT cells and functional cytokines. 16S V34 region amplicon sequencing analysis was used to analyze the intestinal flora of transplant patients. stimulation and coculture assays were used to study the activation and function of MAIT cells. The number and distribution of MAIT cells in intestinal tissues were analyzed by immunofluorescence technology. Our study showed that the number and frequency of MAIT cells in infused grafts in gut aGVHD patients were lower than those in no-gut aGVHD patients. Recipients with a high number of MAITs in infused grafts had a higher abundance of intestinal flora in the early posttransplantation period (+14 days). At the onset of gut aGVHD, the number of MAIT cells decreased in peripheral blood, and the activation marker CD69, chemokine receptors CXCR3 and CXCR4, and transcription factors Rorγt and T-bet tended to increase. Furthermore, when gut aGVHD occurred, the proportion of MAIT17 was higher than that of MAIT1. The abundance of intestinal flora with non-riboflavin metabolic pathways tended to increase in gut aGVHD patients. MAIT cells secreted more granzyme B, tumor necrosis factor (TNF)-α, and interferon (IFN)-γ under the interleukin (IL)-12/IL-18 stimulation [non-T-cell receptor (TCR) signal] and secreted most of the IL-17 under the cluster of differentiation (CD)3/CD28 stimulation (TCR signal). MAIT cells inhibited the proliferation of CD4+ T cells . In conclusion, the lower number of MAIT cells in infused grafts was related to the higher incidence of gut aGVHD, and the number of MAIT cells in grafts may affect the composition of the intestinal flora of recipients early after transplantation. The flora of the riboflavin metabolism pathway activated MAIT cells and promoted the expression of intestinal protective factors to affect the occurrence of gut aGVHD in humans.
肠道急性移植物抗宿主病(aGVHD)是异基因造血干细胞移植(allo-HSCT)后的严重并发症,与高死亡率相关。黏膜相关不变 T(MAIT)细胞是一类在肠道中富集的先天样 T 细胞,可被来自各种微生物的核黄素代谢物激活。然而,关于 MAIT 细胞在人类肠道 aGVHD 发生中的作用或机制知之甚少。在我们的研究中,使用多参数流式细胞术(FCM)评估 MAIT 细胞的数量和功能细胞因子。16S V34 区扩增子测序分析用于分析移植患者的肠道菌群。刺激和共培养测定用于研究 MAIT 细胞的激活和功能。通过免疫荧光技术分析肠道组织中 MAIT 细胞的数量和分布。我们的研究表明,肠道 aGVHD 患者肠道中输注移植物中的 MAIT 细胞数量和频率低于无肠道 aGVHD 患者。输注移植物中 MAIT 数量较高的受者在移植后早期(+14 天)肠道菌群丰度较高。在肠道 aGVHD 发作时,外周血中 MAIT 细胞数量减少,激活标志物 CD69、趋化因子受体 CXCR3 和 CXCR4 以及转录因子 Rorγt 和 T-bet 趋于增加。此外,当发生肠道 aGVHD 时,MAIT17 的比例高于 MAIT1。肠道 aGVHD 患者肠道菌群中无核黄素代谢途径的丰度趋于增加。MAIT 细胞在白细胞介素(IL)-12/IL-18 刺激下(非 T 细胞受体(TCR)信号)分泌更多的颗粒酶 B、肿瘤坏死因子(TNF)-α 和干扰素(IFN)-γ,在 CD3/CD28 刺激下(TCR 信号)分泌大多数 IL-17。MAIT 细胞抑制 CD4+T 细胞的增殖。总之,输注移植物中 MAIT 细胞数量较少与肠道 aGVHD 发生率较高有关,移植物中 MAIT 细胞的数量可能影响移植后早期受者肠道菌群的组成。核黄素代谢途径的菌群激活 MAIT 细胞并促进肠道保护因子的表达,从而影响人类肠道 aGVHD 的发生。